LPV/r

DRUG9 trials

Sponsors

Emory University, IRCCS San Raffaele, The HIV Netherlands Australia Thailand Research Collaboration, Juan A. Arnaiz, Gilead Sciences

Conditions

Acquired Immune Deficiency Syndrome (AIDS)HIVHIV InfectionsHepatitis CLipoatrophyTuberculosis

Phase 2

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

CompletedNCT01138202

The HIV Netherlands Australia Thailand Research CollaborationHIV Infections, Tuberculosis

Start: 2010-11-30End: 2015-12-31Updated: 2020-07-17

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

Active, not recruitingNCT02016924

Gilead SciencesAcquired Immune Deficiency Syndrome (AIDS), HIV Infections

Start: 2014-01-16End: 2027-03-01Updated: 2026-03-20

Phase 3

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

IRCCS San RaffaeleHepatitis C, HIV Infections

Start: 2007-02-28End: 2010-12-31Target: 50Updated: 2009-02-06

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

IRCCS San RaffaeleHepatitis C, HIV Infections

Start: 2007-02-28End: 2010-12-31Target: 60Updated: 2009-02-06

Phase 4

Kaletra Sex/Gender Pharmacokinetics (PK) Study

CompletedNCT00148759

Emory UniversityHIV Infections

Start: 2005-06-30End: 2007-01-31Updated: 2013-12-03

Lopinavir/Ritonavir Monotherapy in Children

CompletedNCT00626301

The HIV Netherlands Australia Thailand Research CollaborationHIV Infections

Start: 2007-11-30End: 2009-09-30Updated: 2015-03-26

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

CompletedNCT00627055

The HIV Netherlands Australia Thailand Research CollaborationHIV Infections

Start: 2008-05-31End: 2010-11-30Updated: 2020-07-17

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

CompletedNCT00978237

Juan A. ArnaizHIV Infections, Lipoatrophy

Start: 2009-10-31End: 2013-11-30Updated: 2014-09-18

Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial

CompletedNCT02431975

Columbia UniversityHIV

Start: 2015-08-31End: 2020-04-30Updated: 2020-08-04

Related Papers

Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.

2022-05-1914 citations

Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants

Clinical Infectious Diseases2021-06-2813 citations

Early antiretroviral treatment of infants to attain HIV remission.

2020-01-0749 citations

Neurodevelopmental assessment of HIV-exposed uninfected and early-treated HIV-infected children: study protocol

BMC Research Notes2018-04-063 citations

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged<b>≥</b>3 to <12 Years

CPT Pharmacometrics & Systems Pharmacology2015-06-1912 citations